Repligen (NASDAQ:RGEN) reported Q4 2017 earnings this Morning, coming in at $0.20 per share, beating Wall Street’s estimates of $0.12 per Share. Revenue for the quarter came in at $41.60 million beating analyst estimates of $41.13 million Recent Insider Trading for Repligen (NASDAQ:RGEN)
- On 1/22/2018 Anthony Hunt, CEO, sold 8,970 with an average share price of $35.95 per share and the total transaction amounting to $322,471.50.
- On 12/14/2017 Howard Benjamin, VP, sold 12,729 with an average share price of $35.34 per share and the total transaction amounting to $449,842.86.
- On 3/21/2017 Karen A Dawes, Director, sold 2,521 with an average share price of $34.12 per share and the total transaction amounting to $86,016.52.
- On 3/20/2017 Howard Benjamin, VP, sold 12,216 with an average share price of $34.62 per share and the total transaction amounting to $422,917.92.
- On 3/20/2017 Thomas F Ryan Jr, Director, sold 4,000 with an average share price of $34.83 per share and the total transaction amounting to $139,320.00.
- On 3/17/2017 Jon Snodgres, CFO, sold 1,909 with an average share price of $34.91 per share and the total transaction amounting to $66,643.19.
Recent Trading for Repligen (NASDAQ:RGEN) Shares of Repligen closed the previous trading session at 34.50 up +2.10 6.48% with 35.470001220703125 shares trading hands.